Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006304 · ClinicalTrials.gov registry record
Long-Term Effects of HIV Exposure and Infection in Children
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 4,150
- Enrollment target
NCT00006304: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00006304 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 4,150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006304 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 4,150 participants
- Enrollment target
Study Summary
As new drugs and vaccines are developed to prevent HIV disease progression and prolong survival of HIV infected patients, the short-term safety and effectiveness of these treatments are evaluated in research studies. However, the long-term effects, whether they are benefits or side effects, need to be studied as well. These long-term effects may have a greater impact on infants and children who are still growing and developing. The purpose of this study is to follow HIV-exposed and HIV infected infants, children, and adolescents who are seen at Pediatric AIDS Clinical Trials Group (PACTG) study sites. These patients will be observed for long-term benefits or any late harmful effects of medications or vaccines.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,150 participants |
| Est. Completion | 2002-05 |
What the finished NCT00006304 record still lists
NCT00006304 is an observational study that tracks outcomes without assigning an intervention. Its 4,150 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00006304 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006304 about?
NCT00006304 is a clinical study titled "Long-Term Effects of HIV Exposure and Infection in Children". As new drugs and vaccines are developed to prevent HIV disease progression and prolong survival of HIV infected patients, the short-term safety and effectiveness of these treatments are evaluated in research studies. However, the long-term effects, whether they are benefits or side effects, need to ...
What is the current status of trial NCT00006304?
This trial is currently completed. The enrollment target is 4,150 participants. Estimated completion is 2002-05.
Who is sponsoring clinical trial NCT00006304?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart